N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof

Details for Australian Patent Application No. 2005215250 (hide)

Owner Pharmacia Corporation

Inventors Finn, Rory F.

Agent Spruson & Ferguson

Pub. Number AU-A-2005215250

PCT Pub. Number WO2005/079838

Priority 10/771,895 04.02.04 US

Filing date 24 January 2005

Wipo publication date 1 September 2005

International Classifications

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/079838 Priority application(s): WO2005/079838

25 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005215254-Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

2005215239-Particulates